Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral
Launched by JOHNS HOPKINS UNIVERSITY · Oct 6, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving healthcare for African American patients with chronic diseases like diabetes, high blood pressure, and heart failure. The researchers have developed a special tool that helps doctors understand the social challenges these patients face, such as financial difficulties or lack of access to resources. By using this tool in primary care clinics and working with community organizations, the study aims to better identify and support patients who need extra help due to their health conditions and social circumstances.
To take part in this trial, you need to be an African American adult aged 18 or older with a low income. Unfortunately, children and individuals with higher incomes or different racial backgrounds cannot participate. If you join the study, you can expect to be part of a program that helps doctors recognize and address both your health and social needs, making it easier for you to get the right care and support. This trial is currently recruiting participants, and your involvement could help improve healthcare for others in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (18+ years old) African-American patients with low income at each clinic
- Exclusion Criteria:
- • Children are excluded from this study. Individuals with high levels of income, and those with race other than African American
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Elham Hatef, MD, MPH
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials